Literature DB >> 3555203

Immunologic mechanisms in intestinal diseases.

S R Targan, M F Kagnoff, M D Brogan, F Shanahan.   

Abstract

The intestine is a unique immunologic organ that comprises an afferent and efferent compartment and provides the host with the ability to respond through several different effector mechanisms against environmental factors. We discuss mechanisms in three intestinal diseases in this overview of the mucosal immune system. Genetic and immunologic factors are important in the pathogenesis of celiac disease, which is characterized by damage to the mucosa of the small intestine with resultant malabsorption. Pathogenic microbes are important environmental agents that interact with the intestinal mucosa and initiate local immune responses. Advances in the understanding of the mucosal immune response to these pathogenic microbes have produced a clear picture of the way in which this specialized immune system works in concert with systemic immunity. As to the autoimmune nature of inflammatory bowel disease, no specific antigen has been shown to incite the inflammatory reactions and neither the target cells nor the effector mechanism involved have been identified. Several factors exist, however, to suggest an autoimmune mechanism and the role of mucosal immunologic factors in this disease.

Entities:  

Mesh:

Year:  1987        PMID: 3555203     DOI: 10.7326/0003-4819-106-6-853

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

1.  Parenteral nutrition in the management of a dog with lymphocytic-plasmacytic enteritis and severe protein-losing enteropathy.

Authors:  I F Lane; E Miller; D C Twedt
Journal:  Can Vet J       Date:  1999-10       Impact factor: 1.008

2.  Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.

Authors:  F Shanahan; B Leman; R Deem; A Niederlehner; M Brogan; S Targan
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

3.  The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions.

Authors:  R L Deem; S R Targan; A Niederlehner; F Shanahan
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

Review 4.  Update on gastric lymphoma.

Authors:  C R Thomas
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

Review 5.  Role of mucosal T-cell-generated cytokines in epithelial cell injury.

Authors:  S R Targan; R L Deem; F Shanahan
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

6.  Ingestion of Giardia lamblia trophozoites by murine Peyer's patch macrophages.

Authors:  D R Hill; R Pohl
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

7.  Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients.

Authors:  L Manzano; M Alvarez-Mon; J A Vargas; J A Girón; L Abreu; A Fernández-Corugedo; L I Román; F Albarran; A Durántez
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

8.  The gut as an inductive site for synovial and extra-articular immune responses in rheumatoid arthritis.

Authors:  C Trollmo; C Sollerman; H Carlsten; A Tarkowski
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

9.  Rare natural killer cell lymphoma found during surveillance endoscopy.

Authors:  Maqsood Khan; Srinadh Komanduri
Journal:  J Gastrointest Cancer       Date:  2009

10.  Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells.

Authors:  R L Deem; F Shanahan; S R Targan
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.